TIM-mediated Inhibition of HIV Release: Cooperation with SERINC and Antagonism by Nef
TIM 介导的 HIV 释放抑制:与 SERINC 的合作和 Nef 的拮抗
基本信息
- 批准号:10242695
- 负责人:
- 金额:$ 33.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAddressAffectAnabolismAntiviral AgentsApoptoticBindingBiological ProcessCD4 Positive T LymphocytesCategoriesCell membraneCellsDataEbola virusEpithelial CellsEquine Infectious Anemia VirusFamilyFluorescence Resonance Energy TransferGenesHIVHIV InfectionsHIV-1Immune responseImmunofluorescence ImmunologicImmunoglobulinsImpairmentInfectionIntegration Host FactorsInterferonsIntrinsic factorKnowledgeLeadLinkLipidsLymphoid CellMediatingMembraneMembrane FluidityMembrane LipidsMembrane MicrodomainsMicroscopyModelingMolecularMucinsMurine leukemia virusNaturePathogenesisPathogenicityPeripheral Blood Mononuclear CellPhosphatidylserinesPhysiologicalPrimatesProcessProductionPropertyProtein FamilyProteinsPublishingReportingRoleSerineStructureT-LymphocyteTechniquesTertiary Protein StructureTestingViralVirionVirusVirus DiseasesWorkexperimental studyimmunoregulationinsightknock-downmacrophagemonocytemutantnef Proteinnovelnovel strategiesparticletraffickingviral entry inhibitorvirus host interaction
项目摘要
The majority of antiviral restriction factors are interferon (IFN) inducible, and are thus collectively referred to
as IFN-stimulated genes (ISGs); many, however, are NOT directly regulated by IFN and remain poorly
characterized. Notably, some of these cellular factors are known to modulate lipids and/or membrane properties,
thereby disrupting the replication of HIV and other viruses. Two recent examples from this category are TIM (T-
cell immunoglobulin and mucin domain) and SERINC (serine incorporator) family proteins, which directly interact
with or possibly regulate the synthesis of phosphatidylserine (PS), thus inhibiting HIV release or infectivity.
Interestingly, our preliminary data and two recent reports published in Nature showed that the lentiviral Nef
proteins effectively antagonize the restriction by TIMs and SERINCs. Moreover, we have recently observed that
SERINC proteins potentiate the ability of TIM-1 to block HIV-1 release and that SERINCs do this by stabilizing
the TIM expression in the viral producer cells. In this application, we propose to test several novel hypotheses
that address the possible link between TIM, SERINC, PS and Nef. Aim 1 will determine how HIV-1 Nef
antagonizes TIM-mediated inhibition of viral release through modulating the synthesis and trafficking of TIM-1
and PS. Aim 2 will focus on understanding of the role of endogenous SERINC proteins in CD4+ T cells that
regulates the TIM expression and stability, as well as in modulating lipids in the viral producer cell and viral
particles, collectively contributing to the inhibition of HIV-1 release and replication. Aim 3 will define the molecular
interplay between SERINC and TIM proteins in viral producer cells, and dissect how HIV-1 Nef protein down-
modulates this process to promote HIV-1 production and infection. Results from the proposed experiments will
provide novel and unified mechanistic insights into the interplay between TIM, SERINC and HIV Nef, and will
enhance our understanding of virus-host interaction and AIDS pathogenesis.
大多数抗病毒限制因子是干扰素(IFN)诱导的,因此统称为干扰素。
IFN刺激基因(ISG);然而,许多基因不受IFN直接调控,
表征了值得注意的是,已知这些细胞因子中的一些调节脂质和/或膜性质,
从而破坏HIV和其他病毒的复制。最近的两个例子是TIM(T-
细胞免疫球蛋白和粘蛋白结构域)和SERINC(丝氨酸蛋白酶)家族蛋白,它们直接相互作用
与或可能调节磷脂酰丝氨酸(PS)的合成,从而抑制HIV释放或感染。
有趣的是,我们的初步数据和最近发表在《自然》杂志上的两份报告显示,慢病毒Nef
蛋白质有效地拮抗TIM和SERINC的限制。此外,我们最近观察到,
SERINC蛋白增强TIM-1阻断HIV-1释放的能力,SERINC通过稳定HIV-1释放来实现这一点。
病毒生产细胞中的TIM表达。在这个应用中,我们提出了几个新的假设测试
解决TIM、SERINC、PS和Nef之间可能存在的联系。目标1将确定HIV-1 Nef
通过调节TIM-1的合成和运输,拮抗TIM介导的病毒释放抑制
和PS。目的2将集中于了解内源性SERINC蛋白在CD 4 + T细胞中的作用,
调节TIM表达和稳定性,以及调节病毒生产细胞和病毒感染细胞中的脂质。
颗粒,共同有助于抑制HIV-1的释放和复制。目标3将定义分子
病毒生产细胞中SERINC和TIM蛋白之间的相互作用,并剖析HIV-1 Nef蛋白如何降低-
调节这一过程以促进HIV-1的产生和感染。从拟议的实验结果将
为TIM、SERINC和HIV Nef之间的相互作用提供了新的和统一的机制见解,
增强我们对病毒-宿主相互作用和艾滋病发病机制的理解。
项目成果
期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
SARS-CoV-2 spreads through cell-to-cell transmission.
- DOI:10.1073/pnas.2111400119
- 发表时间:2022-01-04
- 期刊:
- 影响因子:11.1
- 作者:Zeng C;Evans JP;King T;Zheng YM;Oltz EM;Whelan SPJ;Saif LJ;Peeples ME;Liu SL
- 通讯作者:Liu SL
SERINC proteins potentiate antiviral type I IFN production and proinflammatory signaling pathways.
- DOI:10.1126/scisignal.abc7611
- 发表时间:2021-09-14
- 期刊:
- 影响因子:7.3
- 作者:Zeng, Cong;Waheed, Abdul A.;Li, Tianliang;Yu, Jingyou;Zheng, Yi-Min;Yount, Jacob S.;Wen, Haitao;Freed, Eric O.;Liu, Shan-Lu
- 通讯作者:Liu, Shan-Lu
Role of host factors in SARS-CoV-2 entry.
- DOI:10.1016/j.jbc.2021.100847
- 发表时间:2021-07
- 期刊:
- 影响因子:0
- 作者:Evans JP;Liu SL
- 通讯作者:Liu SL
CD4-Dependent Modulation of HIV-1 Entry by LY6E.
LY6E 对 HIV-1 进入的 CD4 依赖性调节。
- DOI:10.1128/jvi.01866-18
- 发表时间:2019
- 期刊:
- 影响因子:5.4
- 作者:Yu,Jingyou;Liang,Chen;Liu,Shan-Lu
- 通讯作者:Liu,Shan-Lu
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shan-Lu Liu其他文献
Shan-Lu Liu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shan-Lu Liu', 18)}}的其他基金
IFITM-mediated Inhibition of HIV Infection and Viral Countermeasures
IFITM 介导的 HIV 感染抑制及病毒对策
- 批准号:
9376203 - 财政年份:2017
- 资助金额:
$ 33.15万 - 项目类别:
IFITM-mediated Inhibition of HIV Infection and Viral Countermeasures
IFITM 介导的 HIV 感染抑制及病毒对策
- 批准号:
8991472 - 财政年份:2014
- 资助金额:
$ 33.15万 - 项目类别:
IFITM-mediated Inhibition of HIV Infection and Viral Countermeasures
IFITM 介导的 HIV 感染抑制及病毒对策
- 批准号:
8730947 - 财政年份:2014
- 资助金额:
$ 33.15万 - 项目类别:
Inhibition of Ebolavirus Entry by IFITM2 Protein
IFITM2 蛋白抑制埃博拉病毒进入
- 批准号:
8702561 - 财政年份:2014
- 资助金额:
$ 33.15万 - 项目类别:
Restriction of Viral Membrane Fusion and Entry by IFITM Proteins
IFITM 蛋白对病毒膜融合和进入的限制
- 批准号:
8896142 - 财政年份:2014
- 资助金额:
$ 33.15万 - 项目类别:
Novel Cellular Factors Restricting Viral Membrane Fusion
限制病毒膜融合的新细胞因素
- 批准号:
8492736 - 财政年份:2013
- 资助金额:
$ 33.15万 - 项目类别:
Novel Cellular Factors Restricting Viral Membrane Fusion
限制病毒膜融合的新细胞因素
- 批准号:
8605170 - 财政年份:2013
- 资助金额:
$ 33.15万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 33.15万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 33.15万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 33.15万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 33.15万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 33.15万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 33.15万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 33.15万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 33.15万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 33.15万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 33.15万 - 项目类别:
Research Grant














{{item.name}}会员




